SGM
KMTS

Seven Grand Managers’s Kestra Medical Technologies KMTS Stock Holding History

Seven Grand Managers’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.54M Hold
100,000
– – 0.1% 131
2026
Q1 		$1.99M Hold
100,000
– – 0.13% 116
2025
Q4 		$2.65M Buy
+100,000
New +$2.58M 0.2% 100

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Seven Grand Managers's KMTS Position: Q2 2026 in Review

Seven Grand Managers held its Kestra Medical Technologies (KMTS) position steady in Q2 2026 at 100,000 shares worth $2.54M. The position accounts for 0.1% of the portfolio, ranked #131.

Seven Grand Managers first reported a position in KMTS in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.65M in Q4 2025. 109 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Seven Grand Managers held 100,000 shares of Kestra Medical Technologies worth $2.54M as of Q2 2026.
  • Seven Grand Managers left its Kestra Medical Technologies share count unchanged in Q2 2026.
  • Kestra Medical Technologies made up 0.1% of Seven Grand Managers's portfolio in Q2 2026, its #131 holding.
  • Seven Grand Managers first reported a position in Kestra Medical Technologies in Q4 2025 and has held it in 3 quarters since.
  • Seven Grand Managers's Kestra Medical Technologies position peaked at $2.65M in Q4 2025.
  • 109 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Seven Grand Managers's 13F filing for Q2 2026, filed 14 Aug 2026.